NCT03882177View on ClinicalTrials.gov

StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 21, 2020

Primary Completion Date

May 12, 2022

Study Completion Date

December 31, 2022

Conditions
TuberculosisPulmonary Tuberculosis
Interventions
DRUG

Pravastatin

Tablets, administered orally

DRUG

Rifafour

Fixed-dose combination (isoniazid, rifampin, pyrazinamide, and ethambutol) tablets, administered orally

DIETARY_SUPPLEMENT

Vitamin B6

Administered orally.

Trial Locations (1)

1864

PHRU Non-Network CRS, Johannesburg

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03882177 - StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis | Biotech Hunter | Biotech Hunter